11 results match your criteria: "University Medical Centrum Utrecht[Affiliation]"
Eur Urol Open Sci
November 2024
Department of Urology, Amsterdam UMC, Cancer Center Amsterdam, University of Amsterdam, Amsterdam, The Netherlands.
Eur Urol Open Sci
September 2024
Department of Urology, University Medical Centre Utrecht, Utrecht, The Netherlands.
Background And Objective: Video-based learning may be beneficial in surgical education, both in the preparation for surgery and to evaluate surgical performance. The use of a video is not yet anchored in European urology residency programs, and it is unclear how frequently residents use videos. The purpose of this study is to investigate whether and how urology residents utilize videos to prepare for surgical procedures and evaluate their surgical performance.
View Article and Find Full Text PDFJ Geriatr Oncol
July 2023
Department of Geriatric Medicine, University Medical Centrum Utrecht, Utrecht, the Netherlands.
Introduction: Treatment decision-making in cancer is complex and many patients bring their caregiver to appointments to help them make those decisions. Multiple studies show the importance of involving caregivers in the treatment decision-making process. We aimed to explore the preferred and actual involvement of caregivers in the decision-making process of patients with cancer and to see if there are age or cultural background related differences in caregiver involvement.
View Article and Find Full Text PDFJ Endourol
August 2022
Department of Oncological Urology, University Medical Centrum Utrecht, Utrecht, The Netherlands.
Since the transition of surgical robot systems into the medical field, physicians have had to develop new dexterity skills. The ideal learning environment for robotic surgery has yet to be discovered. Virtual reality (VR) simulation is a possible safe and economic method.
View Article and Find Full Text PDFPLoS Negl Trop Dis
April 2020
Department of Microbiology, National Institute for Biomedical Research, Kinshasa, Democratic Republic of the Congo.
Background: Non-typhoidal Salmonella (NTS) are a major cause of bloodstream infection (BSI) in sub-Saharan Africa. This study aimed to assess its longitudinal evolution as cause of BSI, its serotype distribution and its antibiotic resistance pattern in Kisantu, DR Congo.
Methods: As part of a national surveillance network, blood cultures were sampled in patients with suspected BSI admitted to Kisantu referral hospital from 2015-2017.
Orphanet J Rare Dis
January 2020
UOSID Centro Trial, PRINTO, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
The Rare Immunodeficiency, AutoInflammatory and AutoImmune Disease (RITA) network is a European Research Network (ERN) that brings together the leading centres for rare immune disorders. On April 2018 an online survey was sent to all RITA members in order to facilitate the harmonization of data collection in rare immune disorders registries. Currently, as many as 52 different registries collect data on rare immune disorders, of whom 30 (58%) are dedicated primarily to autoimmune diseases, 15 (29%) to primary immunodeficiencies and 12 (23%) to autoinflammatory disorders.
View Article and Find Full Text PDFStroke
August 2016
From the Departments of Radiology (E.M.M.S., K.M.T., C.B.M., H.A.M.), Biomedical Engineering and Physics (E.M.M.S., H.A.M.), and Neurology (Y.B.R.), Academic Medical Center, Amsterdam, The Netherlands; Departments of Radiology (E.M.M.S., W.J.N.) and Medical Informatics (E.M.M.S., W.J.N.), Erasmus Medical Center, Rotterdam, The Netherlands; Departments of Radiology (J.W.D., A.D.H., B.V.) and Neurology (L.J.K.), University Medical Centrum Utrecht, Utrecht, The Netherlands; and Faculty of Applied Sciences, Delft University of Technology, Delft, The Netherlands (W.J.N.).Catharina Hospital, Eindhoven, The NetherlandsCatharina Hospital, Eindhoven, The NetherlandsErasmus Medical Center, Rotterdam, The NetherlandsErasmus Medical Center, Rotterdam, The NetherlandsGelre Hospitals, Apeldoorn, The NetherlandsGelre Hospitals, Apeldoorn, The NetherlandsLeiden University Medical Center, Leiden, The NetherlandsLeiden University Medical Center, Leiden, The NetherlandsMedical Center Haaglanden, The Hague, The NetherlandsMedical Center Haaglanden, The Hague, The NetherlandsOnze Lieve Vrouwe Gasthuis, Amsterdam, The NetherlandsOnze Lieve Vrouwe Gasthuis, Amsterdam, The NetherlandsRadboud University Nijmegen Medical Centre, Nijmegen, The NetherlandsRadboud University Nijmegen Medical Centre, Nijmegen, The NetherlandsRijnstate Hospital, Arnhem, The NetherlandsRijnstate Hospital, Arnhem, The NetherlandsSt. Antonius Hospital, Nieuwegein, The NetherlandsSt. Antonius Hospital, Nieuwegein, The NetherlandsSt. Elisabeth Hospital, Tilburg, The NetherlandsSt. Elisabeth Hospital, Tilburg, The NetherlandsSt. Franciscus Hospital, Rotterdam, The NetherlandsSt. Franciscus Hospital, Rotterdam, The NetherlandsVU Medical Center, Amsterdam, The NetherlandsVU Medical Center, Amsterdam, The NetherlandsUniversity Medical Center Utrecht, Utrecht, The NetherlandsUniversity Medical Center Utrecht, Utrecht, The NetherlandsUniversity Medical Center Utrecht, Utrecht, The NetherlandsUniversity Medical Center Utrech
Background And Purpose: Preclinical studies showed that thrombus permeability improves recombinant tissue-type plasminogen activator (r-tPA) efficacy. We hypothesize that thrombus permeability estimated from radiological imaging is associated with improved recanalization after treatment with intravenously administered r-tPA (r-tPA) and with better functional outcome.
Methods: We assessed thrombus attenuation increase (TAI) in patients from the Dutch Acute Stroke Study with an occlusion of an intracranial artery on computed tomographic angiography.
Cell Stress Chaperones
July 2016
Biomedical Research Department, Center for Genetic Engineering and Biotechnology, P.O. Box 6162, Havana, 11300, Cuba.
Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by a chronic relapsing-remitting joint inflammation. Perturbations in the balance between CD4 + T cells producing IL-17 and CD4 + CD25(high)FoxP3 + Tregs correlate with irreversible bone and cartilage destruction in RA. APL1 is an altered peptide ligand derived from a CD4+ T-cell epitope of human HSP60, an autoantigen expressed in the inflamed synovium, which increases the frequency of CD4 + CD25(high)FoxP3+ Tregs in peripheral blood mononuclear cells from RA patients.
View Article and Find Full Text PDFExpert Opin Drug Saf
September 2016
a Department of Pediatrics, Section Pediatric Rheumatology , Wilhelmina Children's Hospital, University Medical Centrum Utrecht, Utrecht , The Netherlands.
Introduction: Interleukin-1 (IL-1) is the key molecule of a strong pro-inflammatory pathway in the innate immune system. The IL-1 family harbors components with pro- and anti-inflammatory effects essential for the regulation of the inflammation process. Auto-inflammatory diseases and systemic onset juvenile idiopathic arthritis (JIA) are examples of chronic inflammatory diseases that are IL-1 dependent.
View Article and Find Full Text PDFDig Liver Dis
July 2015
Department of Gastroenterology and Hepatology, University Medical Centrum Utrecht, Utrecht, The Netherlands. Electronic address:
Background: Real-life prospective data on adherence to nucleos(t)ide analogues in chronic hepatitis B patients are scarce.
Aims: We investigated adherence to entecavir in relation to virological response.
Methods: In this prospective study, we provided 100 consecutive chronic hepatitis B patients with a medication dispenser that monitored entecavir intake during 16 weeks therapy.
J Natl Cancer Inst
January 2015
Molecular and Population Genetics Laboratory, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK (DNC, IPMT); Oxford Cancer Centre, Churchill Hospital, Oxford, UK (DNC); Department of Pathology (ES, NtH, VTHBMS, TB) and Department of Clinical Oncology (RAN, CLC), Leiden University Medical Center, Leiden, the Netherlands; Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland (NV, AN, PJW); Vesalius Research Center (VRC), VIB, Leuven, Belgium (JD, DL); Laboratory of Translational Genetics, Department of Oncology, KU Leuven, Belgium (FA, DL); Department of Obstetrics & Gynecology, Division of Gynecologic Oncology, University Hospitals Gasthuisberg, Leuven, Belgium (FA); Genomic Medicine Theme, Oxford Comprehensive Biomedical Research Centre, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK (IPMT); Department of Radiation Oncology, University Medical Centrum Utrecht, the Netherlands (IMJS); Department of Radiation Oncology, Medisch Spectrum Twente, Enschede, the Netherlands (JJJ).
Background: Current risk stratification in endometrial cancer (EC) results in frequent over- and underuse of adjuvant therapy, and may be improved by novel biomarkers. We examined whether POLE proofreading mutations, recently reported in about 7% of ECs, predict prognosis.
Methods: We performed targeted POLE sequencing in ECs from the PORTEC-1 and -2 trials (n = 788), and analyzed clinical outcome according to POLE status.